Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.93
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,287.31m
  • Volume: 248,295
  • Market Cap: £5.72m
  • RiskGrade: 429

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -190.3% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2.9 n/a
Pr/Book 1.6  
Latest F'cast
Revenue 9.7% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Verici DX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (8.33) (5.90)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (11.41) (6.90)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1.01 (8.73) (5.10)¢ n/a n/a n/a n/a 0.0%
31-Dec-24 3.34 (5.87) (2.50)¢ n/a n/a n/a n/a 0.0%
31-Dec-25 3.66 (6.92) (0.90)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Verici DX Company Announcements

No recent information was found.

Verici DX ShareCast News

Verici Dx raises additional £0.19m through retai... 12-Jun-2026 ShareCast
Verici Dx to raise up to £5m to accelerate diagn... 21-Jul-2025 ShareCast
Verici Dx reports record Tutivia orders, downgra... 07-Apr-2025 ShareCast

Latest Verici DX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Verici DX Market Data

Currency UK Pounds
Share Price 0.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.93
52 Week Low 0.20
Volume 248,295
Shares Issued 2,287.31m
Market Cap £5.72m
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.71% below the market average32.71% below the market average32.71% below the market average32.71% below the market average32.71% below the market average
12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average
Price Trend
97.82% below the market average97.82% below the market average97.82% below the market average97.82% below the market average97.82% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
25.52% above the market average25.52% above the market average25.52% above the market average25.52% above the market average25.52% above the market average
10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average

Verici DX Dividends

No dividends found

Trades for 12-Aug-2026

Time Volume / Share Price
14:29 86 @ 0.30p
13:49 95,630 @ 0.20p
12:49 88,000 @ 0.25p
11:45 60,840 @ 0.30p
11:28 4 @ 0.30p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page